Scientists test Patient's own cells to fight Diabetes-Related kidney damage
NCT ID NCT06866158
Summary
This early-stage trial is testing whether a one-time injection of a patient's own specially prepared immune cells can help control diabetic kidney disease. The study will enroll 80 adults with type 2 diabetes who show early signs of kidney damage (albuminuria). Researchers aim to see if this cell-based therapy can reduce protein in the urine and improve kidney health by targeting inflammation and blood vessel function.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETIC KIDNEY DISEASE (DKD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Gatot Soebroto Central Army Hospital
Jakarta Pusat, DKI Jakarta - Jakarta, 10410, Indonesia
Conditions
Explore the condition pages connected to this study.